Antonella Zanobetti1, Joel Schwartz. 1. Department of Environmental Health, Harvard School of Public Health, Boston, MA 02215, USA. azanobet@hsph.harvard.edu
Abstract
RATIONALE: Time series studies have reported associations between ozone and daily deaths. Only one cohort study has reported the effect of long-term exposures on deaths, and little is known about effects of chronic ozone exposure on survival in susceptible populations. OBJECTIVES: We investigated whether ozone was associated with survival in four cohorts of persons with specific diseases in 105 United States cities, treating ozone as a time varying exposure. METHODS: We used Medicare data (1985–2006), and constructed cohorts of persons hospitalized with chronic conditions that might predispose to ozone effects: chronic obstructive pulmonary disease, diabetes, congestive heart failure, and myocardial infarction. Yearly warm-season average ozone was merged to the individual follow-up in each city. We applied Cox proportional hazard model for each cohort within each city, adjusting for individual risk factors, temperature, and city-specific long-term trends. MEASUREMENTS AND MAIN RESULTS: We found significant associations with a hazard ratio for mortality of 1.06 (95% confidence interval [CI], 1.03–1.08) per 5-ppb increase in summer average ozone for persons with congestive heart failure; of 1.09 (95% CI, 1.06–1.12) with myocardial infarction; of 1.07 (95% CI, 1.04–1.09) with chronic obstructive pulmonary disease; and of 1.07 (95% CI, 1.05–1.10) for diabetics.We also found that the effect varied by region, but that this was mostly explained by mean temperature, which is likely a surrogate of air conditioning use, and hence exposure. CONCLUSIONS: This is the first study that follows persons with specific chronic conditions, and shows that long-term ozone exposure is associated with increased risk of death in these groups.
RATIONALE: Time series studies have reported associations between ozone and daily deaths. Only one cohort study has reported the effect of long-term exposures on deaths, and little is known about effects of chronic ozone exposure on survival in susceptible populations. OBJECTIVES: We investigated whether ozone was associated with survival in four cohorts of persons with specific diseases in 105 United States cities, treating ozone as a time varying exposure. METHODS: We used Medicare data (1985–2006), and constructed cohorts of persons hospitalized with chronic conditions that might predispose to ozone effects: chronic obstructive pulmonary disease, diabetes, congestive heart failure, and myocardial infarction. Yearly warm-season average ozone was merged to the individual follow-up in each city. We applied Cox proportional hazard model for each cohort within each city, adjusting for individual risk factors, temperature, and city-specific long-term trends. MEASUREMENTS AND MAIN RESULTS: We found significant associations with a hazard ratio for mortality of 1.06 (95% confidence interval [CI], 1.03–1.08) per 5-ppb increase in summer average ozone for persons with congestive heart failure; of 1.09 (95% CI, 1.06–1.12) with myocardial infarction; of 1.07 (95% CI, 1.04–1.09) with chronic obstructive pulmonary disease; and of 1.07 (95% CI, 1.05–1.10) for diabetics.We also found that the effect varied by region, but that this was mostly explained by mean temperature, which is likely a surrogate of air conditioning use, and hence exposure. CONCLUSIONS: This is the first study that follows persons with specific chronic conditions, and shows that long-term ozone exposure is associated with increased risk of death in these groups.
Authors: R A Jörres; O Holz; W Zachgo; P Timm; S Koschyk; B Müller; F Grimminger; W Seeger; F J Kelly; C Dunster; T Frischer; G Lubec; M Waschewski; A Niendorf; H Magnussen Journal: Am J Respir Crit Care Med Date: 2000-06 Impact factor: 21.405
Authors: Mehrdad Arjomandi; Allyson Witten; Emilio Abbritti; Kurt Reintjes; Isabelle Schmidlin; Wenwu Zhai; Colin Solomon; John Balmes Journal: Am J Respir Crit Care Med Date: 2005-06-03 Impact factor: 21.405
Authors: Peter Höppe; Annette Peters; Gerlinde Rabe; Georg Praml; Jutta Lindner; Gert Jakobi; Günter Fruhmann; Dennis Nowak Journal: Int J Hyg Environ Health Date: 2003-10 Impact factor: 5.840
Authors: Angela M Groves; Andrew J Gow; Christopher B Massa; LeRoy Hall; Jeffrey D Laskin; Debra L Laskin Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-08-30 Impact factor: 5.464
Authors: Zhuowei Li; Robert M Tighe; Feifei Feng; Julie G Ledford; John W Hollingsworth Journal: J Biochem Mol Toxicol Date: 2012-11-20 Impact factor: 3.642
Authors: Angela M Groves; Andrew J Gow; Christopher B Massa; Jeffrey D Laskin; Debra L Laskin Journal: Am J Respir Cell Mol Biol Date: 2012-08-09 Impact factor: 6.914
Authors: Desinia B Miller; Samantha J Snow; Andres Henriquez; Mette C Schladweiler; Allen D Ledbetter; Judy E Richards; Debora L Andrews; Urmila P Kodavanti Journal: Toxicol Appl Pharmacol Date: 2016-06-28 Impact factor: 4.219